|
|
||||||||
From the Departments of Physiology and Neurological Sciences (Drs. Schauf, Davis and Rooney), Rush University, and the Department of Neurology, Pritzker School of Medicine (Drs. Antel and Amason), University of Chicago, Chicago, IL.
Neuroelectric blocking activity, similar in nature to that previously observed in sera from patients with multiple sclerosis, has been observed in sera from 18 patients with amyotrophic lateral sclerosis. Results concerning the application of plasma exchange to this patient population are also described.
This work was supported by Research Career Development Award No. K04NS00004 (Dr Schauf), by National Multiple Sclerosis Society grant No. RG1230A1 (Dr. Schauf), the Morris Multiple Sclerosis Research Fund (Dr. Davis), and grants from the Muscular Dystrophy Association of America (Dr. Antel) and the Amyotrophic Lateral Sclerosis Society of America (Dr. Arnason).
Address correspondence and reprint requests to Dr. Schauf, Department of Physiology, Rush University, Chicago, IL 60637.
Accepted for publication November 9, 1979.
This article has been cited by other articles:
![]() |
R. H. Brown Jr, S. L. Hauser, H. Harrington, and H. L. Weiner Failure of Immunosuppression With a Ten- to 14-Day Course of High-Dose Intravenous Cyclophosphamide to Alter the Progression of Amyotrophic Lateral Sclerosis Arch Neurol, April 1, 1986; 43(4): 383 - 384. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |